Cargando…

Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis

BACKGROUND: Poor adherence with oral bisphosphonates (BPs) can mitigate their therapeutic benefit for osteoporosis and is a significant clinical burden. Most previous studies regarding adherence with oral BPs have focused on postmenopausal osteoporosis, but little attention has been given to patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Ji-Heh, Park, Eun-Kyoung, Koo, Dong-Wan, Lee, Shinwon, Lee, Sun-Hee, Kim, Geun-Tae, Lee, Seung-Geun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387221/ https://www.ncbi.nlm.nih.gov/pubmed/28399834 http://dx.doi.org/10.1186/s12891-017-1514-4

Ejemplares similares

Male patients with rheumatoid arthritis have an increased risk of osteoporosis: Frequency and risk factors
por: Kweon, Seong-Min, et al.
Publicado: (2018)

Drug survival and the associated predictors in South Korean patients with rheumatoid arthritis receiving tacrolimus
por: Park, Eun-Young, et al.
Publicado: (2018)

Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?
por: Nho, Jae-Hwi, et al.
Publicado: (2016)

Positive Effects of Biologics on Osteoporosis in Rheumatoid Arthritis
por: Kim, Yunkyung, et al.
Publicado: (2023)

Higher serum uric acid levels are associated with reduced risk of hip osteoporosis in postmenopausal women with rheumatoid arthritis
por: Lee, Han-Na, et al.
Publicado: (2020)

Which Bisphosphonate? It's the Compliance!: Decision Analysis
por: Lee, You Jin, et al.
Publicado: (2016)

Impact on Bisphosphonate Persistence and Compliance: Daily Postprandial Administration
por: Park, Chan Ho, et al.
Publicado: (2019)

Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA
por: Kishimoto, Hideaki, et al.
Publicado: (2015)

Impact of the Training on the Compliance and Persistence of Weekly Bisphosphonate Treatment in Postmenopausal Osteoporosis: A Randomized Controlled Study
por: Tüzün, Şansın, et al.
Publicado: (2013)

Oral bisphosphonate compliance and persistence: a matter of choice?
por: Silverman, S. L., et al.
Publicado: (2010)

Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
por: Suzuki, Takako, et al.
Publicado: (2017)

Associations of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Monocyte-to-Lymphocyte Ratio with Osteoporosis and Incident Vertebral Fracture in Postmenopausal Women with Rheumatoid Arthritis: A Single-Center Retrospective Cohort Study
por: Song, Byung-Wook, et al.
Publicado: (2022)

Is the frequency of metabolic syndrome higher in South Korean women with rheumatoid arthritis than in healthy subjects?
por: Lee, Seung-Geun, et al.
Publicado: (2013)

The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis
por: Lee, Joo-Hyun, et al.
Publicado: (2016)

Position Statement: Drug Holiday in Osteoporosis Treatment with Bisphosphonates in South Korea
por: Lee, Seung Hun, et al.
Publicado: (2015)

Diagnostic Value of Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and Monocyte-to-Lymphocyte Ratios for the Assessment of Rheumatoid Arthritis in Patients with Undifferentiated Inflammatory Arthritis
por: Song, Byung-Wook, et al.
Publicado: (2022)

Effect of Dosing Interval on Compliance of Osteoporosis Patients on Bisphosphonate Therapy: Observational Study Using Nationwide Insurance Claims Data
por: Lee, Hyunil, et al.
Publicado: (2021)

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
por: Höer, Ariane, et al.
Publicado: (2009)

Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception
por: Suh, Young Sun, et al.
Publicado: (2018)

Relationship between serum adipokine levels and radiographic progression in patients with ankylosing spondylitis: A preliminary 2-year longitudinal study
por: Park, Ji-Heh, et al.
Publicado: (2017)

Long-Term Oral Bisphosphonate Compliance Focusing on Switching of Prescription Pattern
por: Ko, Kyung Rae, et al.
Publicado: (2020)

Response to comment on “Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception”
por: Suh, Young Sun, et al.
Publicado: (2018)

The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review
por: Adachi, Jonathan, et al.
Publicado: (2007)

Influence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: An observational study in Turkish patients with postmenopausal osteoporosis
por: Akarırmak, Ülkü, et al.
Publicado: (2016)

Predictors of joint damage in patients with rheumatoid arthritis: focus on short- and long-term effects of intra-articular glucocorticoid injections
por: Koh, Jung Hee, et al.
Publicado: (2021)

Cultural Adaptation of a Compliance Questionnaire for Patients with Rheumatoid Arthritis to a Korean Version
por: Lee, Ju Yeun, et al.
Publicado: (2011)

The association between Bell's palsy and rheumatoid arthritis: A longitudinal study
por: Lee, Sang-Yeon, et al.
Publicado: (2020)

Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
por: Cotté, François-Emery, et al.
Publicado: (2011)

Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review
por: Fatoye, F, et al.
Publicado: (2019)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Bisphosphonates adherence for treatment of osteoporosis
por: Vieira, Helena Parente, et al.
Publicado: (2013)

Compliance and persistence with osteoporosis medications: A critical review of the literature
por: Silverman, Stuart, et al.
Publicado: (2010)

Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?
por: Lee, Joo-Hyun, et al.
Publicado: (2014)

Osteoporosis diagnostics in patients with rheumatoid arthritis
por: Węgierska, Małgorzata, et al.
Publicado: (2016)

Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons
por: Llorente, Irene, et al.
Publicado: (2020)

Mechanisms of Systemic Osteoporosis in Rheumatoid Arthritis
por: Pietschmann, Peter, et al.
Publicado: (2022)

Comparative Analysis of Fecal Microbiota Composition Between Rheumatoid Arthritis and Osteoarthritis Patients
por: Lee, Jin-Young, et al.
Publicado: (2019)

Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy
por: Aeberli, Daniel, et al.
Publicado: (2013)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vop7hjr61k8filgo5s2uicpkrt